Nitrosamines, cannabinoids, production single use systems, solvent residuals
We have published a series of new analytical chemistry pages.
At MET we understand the needs of the medical and drug delivery device industries. These four new pages explain part of our support to pharmaceutical industry.
- nitrosamine quantification,
- solvent residual analysis,
- leachables studies for single use systems
- and cannabis product purity and strength testing.
All areas where analytical support is needed in a changing landscape.
The EMA deadline for the quantification of nitrosamines, following your risk analysis, is 26th of September 2022 for chemical medicines and the 1st of July 2023 for biological medicines.